Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Therapixel logo — Artificial Intelligence for efficient breast cancer screenin...

Therapixel

Artificial Intelligence for efficient breast cancer screening

Founded 2013 France France 49 employees Series B Total: $24.80M AI, Health Care +2

General Information

Company Name Therapixel
Founded Year 2013
Location France France
Employees 49
Industries AI, Health Care, Medical Devices +1
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Therapixel. To contact Therapixel, visit therapixel.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Therapixel compare?

A PDF of Therapixel and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Therapixel soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Therapixel

Therapixel is a leading French software company specializing in artificial intelligence for medical imaging, with a focus on efficient breast cancer screening. Their AI algorithm achieved a milestone by winning the Digital Mammography DREAM Challenge, the largest Artificial Intelligence challenge ever organized. In its early years, Therapixel developed image visualization software for surgeons, streamlining image access from patient consultation to the operating room using gesture control and intuitive user interfaces. The company, founded in 2013, operates at the intersection of AI, Health Care, Medical Devices, and Machine Learning, with its headquarters based in France. Notably, Therapixel has secured a significant €15.00M Series B investment on May 12, 2022. The investment was led by a consortium of investors including Omnes Capital, Verve Ventures, Crédit Mutuel Innovation, Elaia, Région Sud Investissement, Fraser, M Capital Partners, IT-Translation, CapHorn Invest, and Sham.

Business keywords: Medical Imaging, Breast Cancer Screening, Digital Radiologist, Software Development, AI-based Software, Image Visualization, Digital Mammography, DREAM Challenge Winner, Gesture Control, Surgeon Software, Cancer Detection, Characterization, Expert System

Services & Products

Development of AI-driven medical imaging technology for enhanced breast cancer detection and radiology diagnostics

Target Customers

Healthcare providers radiologists medical imaging centers

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series B €15.00M 10
Omnes Capital Verve Ventures Crédit Mutuel Innovation
Omnes Capital, Verve Ventures +8
12 May 2022
Seed Round $4.20M -
03 Jun 2021
Series A €5.00M 5
Omnes Capital Crédit Agricole Région Sud Investissement
Omnes Capital, Crédit Agricole +3
13 Mar 2019
Seed Round €600.00K 3
Paca Investissement Conseil Plus Gestion
Paca Investissement, Conseil Plus Gestion +1
24 Nov 2015

Therapixel Alternatives & Competitors

View All Alternatives
Therapixel vs
b-rayZ
b-rayZ Switzerland

Empower Mammography through Artificial Intelligence

Series A
20 employees
AI, Analytics
Compare Therapixel vs b-rayZ
Therapixel vs
Elaitra
Elaitra United Kingdom

Improving breast cancer detection with state-of-the-art neural networks.

Pre-Seed
6 employees
AI, Health Care
Compare Therapixel vs Elaitra
Therapixel vs
CureMetrix
CureMetrix United States

CureMetrix supports the radiologist to improve mammography and save lives.

Series A
43 employees
AI, Biotechnology
View all alternatives

FAQ About Therapixel

Artificial Intelligence for efficient breast cancer screening
Therapixel was founded in 2013.
Therapixel is headquartered in France.
Therapixel operates in AI, Health Care, Medical Devices and Machine Learning. Its work centres on Medical Imaging, Breast Cancer Screening, Digital Radiologist and Software Development. Its customers include Healthcare providers, radiologists and medical imaging centers.
Therapixel has approximately 49 employees.
Therapixel has completed 4 funding rounds, raising a total of $24.80M. The latest funding stage is Series B.
Therapixel offers: Development of AI-driven medical imaging technology for enhanced breast cancer detection and radiology diagnostics.
Top alternatives and competitors to Therapixel include b-rayZ, Elaitra, CureMetrix, Lunit Cancer Screening, MICA AI Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Therapixel and b-rayZ are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Therapixel, https://bouncewatch.com/company/therapixel, updated 11 June 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes